These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 19400303)

  • 21. Solution- and solid-phase synthesis and anti-HIV activity of maslinic acid derivatives containing amino acids and peptides.
    Parra A; Rivas F; Lopez PE; Garcia-Granados A; Martinez A; Albericio F; Marquez N; Muñoz E
    Bioorg Med Chem; 2009 Feb; 17(3):1139-45. PubMed ID: 19135380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amphiphilic helical peptides containing two acridine moieties display picomolar affinity toward HIV-1 RRE and TAR.
    Lee Y; Hyun S; Kim HJ; Yu J
    Angew Chem Int Ed Engl; 2008; 47(1):134-7. PubMed ID: 17987636
    [No Abstract]   [Full Text] [Related]  

  • 23. A novel peptide shows excellent anti-HIV-1 potency as a gp41 fusion inhibitor.
    Liu W; An X; Wang J; Zhang X; Tan J; Zhou Z; Zeng Y
    Bioorg Med Chem Lett; 2018 Mar; 28(5):910-914. PubMed ID: 29433929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-function study and anti-HIV activity of synthetic peptide analogues derived from viral chemokine vMIP-II.
    Luo Z; Fan X; Zhou N; Hiraoka M; Luo J; Kaji H; Huang Z
    Biochemistry; 2000 Nov; 39(44):13545-50. PubMed ID: 11063591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HBV polymerase-derived peptide exerts an anti-HIV-1 effect by inhibiting the acetylation of viral integrase.
    Kim H; Lee SY; Choi YM; Kim BJ
    Biochem Biophys Res Commun; 2018 Jun; 501(2):541-546. PubMed ID: 29752938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marine natural products with anti-HIV activities in the last decade.
    Zhou X; Liu J; Yang B; Lin X; Yang XW; Liu Y
    Curr Med Chem; 2013; 20(7):953-73. PubMed ID: 23210782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An effective conjugation strategy for designing short peptide-based HIV-1 fusion inhibitors.
    Liang G; Wang H; Chong H; Cheng S; Jiang X; He Y; Wang C; Liu K
    Org Biomol Chem; 2016 Aug; 14(33):7875-82. PubMed ID: 27454320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peptide triazole inactivators of HIV-1: how do they work and what is their potential?
    Chaiken I; Rashad AA
    Future Med Chem; 2015; 7(17):2305-10. PubMed ID: 26599515
    [No Abstract]   [Full Text] [Related]  

  • 29. Computational prediction of anti HIV-1 peptides and in vitro evaluation of anti HIV-1 activity of HIV-1 P24-derived peptides.
    Poorinmohammad N; Mohabatkar H; Behbahani M; Biria D
    J Pept Sci; 2015 Jan; 21(1):10-6. PubMed ID: 25407510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the cyclic peptide backbone in the anti-HIV activity of the cyclotide kalata B1.
    Daly NL; Gustafson KR; Craik DJ
    FEBS Lett; 2004 Sep; 574(1-3):69-72. PubMed ID: 15358541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-HIV activities of novel synthetic peptide conjugated chitosan oligomers.
    Karagozlu MZ; Karadeniz F; Kim SK
    Int J Biol Macromol; 2014 May; 66():260-6. PubMed ID: 24556119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marked increase in anti-HIV activity, as well as inhibitory activity against HIV entry mediated by CXCR4, linked to enhancement of the binding ability of tachyplesin analogs to CXCR4.
    Xu Y; Tamamura H; Arakaki R; Nakashima H; Zhang X; Fujii N; Uchiyama T; Hattori T
    AIDS Res Hum Retroviruses; 1999 Mar; 15(5):419-27. PubMed ID: 10195751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design of highly potent HIV fusion inhibitors based on artificial peptide sequences.
    Shi W; Cai L; Lu L; Wang C; Wang K; Xu L; Zhang S; Han H; Jiang X; Zheng B; Jiang S; Liu K
    Chem Commun (Camb); 2012 Dec; 48(94):11579-81. PubMed ID: 23093045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural characterization and anti-HIV-1 activities of arginine/glutamate-rich polypeptide Luffin P1 from the seeds of sponge gourd (Luffa cylindrica).
    Ng YM; Yang Y; Sze KH; Zhang X; Zheng YT; Shaw PC
    J Struct Biol; 2011 Apr; 174(1):164-72. PubMed ID: 21195767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptide-lead CXCR4 antagonists with high anti-HIV activity.
    Fujii N; Tamamura H
    Curr Opin Investig Drugs; 2001 Sep; 2(9):1198-202. PubMed ID: 11717804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bauhinia variegata var. variegata trypsin inhibitor: from isolation to potential medicinal applications.
    Fang EF; Wong JH; Bah CS; Lin P; Tsao SW; Ng TB
    Biochem Biophys Res Commun; 2010 Jun; 396(4):806-11. PubMed ID: 20435016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
    Sugaya M; Nishino N; Katoh A; Harada K
    J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multivalent catanionic GalCer analogs derived from first generation dendrimeric phosphonic acids.
    Pérez-Anes A; Stefaniu C; Moog C; Majoral JP; Blanzat M; Turrin CO; Caminade AM; Rico-Lattes I
    Bioorg Med Chem; 2010 Jan; 18(1):242-8. PubMed ID: 19942442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-HIV-1 activity of anti-TAR polyamide nucleic acid conjugated with various membrane transducing peptides.
    Tripathi S; Chaubey B; Ganguly S; Harris D; Casale RA; Pandey VN
    Nucleic Acids Res; 2005; 33(13):4345-56. PubMed ID: 16077030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological activity of acylated and telomerized peptides as potential HIV-fixation inhibitors.
    Lacoux X; Barragan V; Dewynter G; Leydet A; Roque JP; Montero JL
    Farmaco; 1996 Dec; 51(12):767-73. PubMed ID: 9050208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.